Phase Genomics Advances Breakthrough Cytogenomics with the Element AVITI System for Acute Myeloid Leukemia

SEATTLE–(BUSINESS WIRE)– #OncoTerra–Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation sequencing system. The platform offers a revolutionary leap toward rapid risk stratification for acute myeloid leukemia (AML). Traditional…
Click here to view original post